CNBX Pharmaceuticals Inc.’s Q4 2026 10-K window runs Nov 27, 2026 to Dec 3, 2026.
Based on 8 prior 10-K filings.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR